Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...
Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics
Immunetics,a developer of infectious disease diagnostic tests,has appointed John Yonkin as the company's new chief executive officer(CEO),effective from 1 December 2012. Prior to joining Immunetics,Yonkin served at Alere as vice president ...
Tags: Immunetics, infectious disease diagnostic tests, BacTx rapid test
GlaxoSmithKline's (GSK) Promacta has won FDA approval as thrombocytopenia therapy in chronic hepatitis C patients. Promacta, brand name of eltrombopag in the US, will enable thrombocytopenia patients suffering from chronic hepatitis C ...
Tags: FDA approval, thrombocytopenia therapy, chronic hepatitis C
The European Union (EU) has granted CE mark to Alpha Orthopaedics' AT3 System, designed for relieving pain associated with tendinosis and fasciosis. Using non-invasive ReleF technology, the device delivers RF energy and by its cooling ...
Tags: Pain Relieving System, CE, EU, AT3 System
The US Food and Drug Administration (FDA) has granted clearance to Fenwal for two new indications for collection of plasma products on its cell separation devices, thus providing blood centers more flexibility to collect plasma on mobile ...
Tags: cell separation devices, collection of plasma products, plasma products
Accumetrics has received Health Canada license for its VerifyNow system, designed to measure platelet reactivity in patients on antiplatelet medications including aspirin and P2Y12 inhibitors (clopidogrel). As per the license, VerifyNow ...
Tags: VerifyNow system, platelet reactivity system, P2Y12 inhibitors, aspirin
Semprus BioSciences, a subsidiary of Teleflex, has received CE mark for its Nylus peripherally inserted central catheter (PICC) with Semprus Sustain technology from its notified body, the Netherlands-based DEKRA Certification Group. The ...
Tags: Nylus peripherally inserted central catheter, PICC, Nylus PICC
Nfocus Neuromedical has reported positive one-year follow-up results from an ongoing clinical study of its Luna Aneurysm Embolization system (AES). CE-marked Luna AES is an oval shaped self-expandable, multi-layer, Nitinol alloy-based ...
Tags: Nfocus Neuromedical, Luna AES, aneurysms
The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation system. The Magellan system utilizes ...
Tags: FDA, Anticoagulant Citrate Dextrose Solution, clinical technology
Ligand Pharmaceuticals partner GlaxoSmithKline has submitted regulatory applications in the US and European Union for the use of eltrombopag (Promacta/Revolade) to increase platelet counts in patients with hepatitis C. A supplemental ...